Studying a Novel Anti-Cancer Drug for Histiocytic Sarcoma
Researchers are conducting a clinical trial to evaluate the ability of the drug trametinib to control tumor growth and improve outcomes for dogs with histiocytic sarcoma, an aggressive and usually fatal canine cancer.